Capstone Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Hold |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $952K | Hold |
|
|||||
|
2023
Q4 | $1.05M | Hold |
|
|||||
|
2023
Q3 | $964K | Hold |
|
|||||
|
2023
Q2 | $945K | Sell |
|
|||||
|
2023
Q1 | $1.06M | Buy |
|
|||||
|
2022
Q4 | $1.13M | Hold |
|
|||||
|
2022
Q3 | $924K | Hold |
|
|||||
|
2022
Q2 | $903K | Buy |
|
|||||
|
2022
Q1 | $207K | Buy |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $906K | Sell |
|
|||||
|
2020
Q4 | $1.42M | Buy |
|
|||||
|
2020
Q3 | $1.1M | Sell |
|
|||||
|
2020
Q2 | $2.85M | Sell |
|
|||||
|
2020
Q1 | $2.37M | Sell |
|
|||||
|
2019
Q4 | $2.41M | Buy |
|
|||||
|
2019
Q3 | $1.52M | Sell |
|
|||||
|
2019
Q2 | $2.74M | Sell |
|
|||||
|
2019
Q1 | $3.02M | Sell |
|
|||||
|
2018
Q4 | $2.98M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $527K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.32M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $549K | Sell |
|
|||||
|
2015
Q3 | $846K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $2.31M | Buy |
|